About: Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
Creator	Jawhara, Samir Dangi, Anil Oria, Reinaldo Qie, Yaqing
source	Medline; PMC
abstract	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes severe respiratory tract infections in humans (COVID-19), has become a global health concern. Currently, several vaccine candidates against SARS-CoV-2 are in clinical trials but approval of these vaccines is likely to take a long time before they are available for public use. In a previous report, the importance of passive immunity and how immunoglobulin (Ig)G collected from recovered coronavirus patients could help in the protection against COVID-19 and boost the immune system of new patients was reported. Passive immunity by immunoglobulin transfer is a concept employed by most mammals and bovine IgG has a role to play in human therapy. IgG is one of the major components of the immunological activity found in cow's milk and colostrum. Heterologous transfer of passive immunity associated with the consumption of bovine immune milk by humans has been investigated for decades for its immunological activity against infections. This short review focuses on passive immunity and how microfiltered raw immune milk or colostrum collected from cows vaccinated against SARS-CoV-2 could provide short-term protection against SARS-CoV-2 infection in humans and could be used as an option until a vaccine becomes commercially available.
has issue date	2020-07-28(xsd:dateTime)
bibo:doi	10.3389/fimmu.2020.01888
bibo:pmid	32849647
has license	cc-by
sha1sum (hex)	13b2c4dd4a01e194a56f9187fc983208608ec713
schema:url	https://doi.org/10.3389/fimmu.2020.01888
resource representing a document's title	Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
has PubMed Central identifier	PMC7399080
has PubMed identifier	32849647
schema:publication	Front Immunol
resource representing a document's body	covid:13b2c4dd4a01e194a56f9187fc983208608ec713#body_text
is schema:about of	named entity 'Immune' named entity 'COVID' named entity 'virus' named entity 'influenza A virus' named entity 'SARS-CoV-2' named entity 'colostrum' named entity 'public health emergency of international concern' named entity 'clinical trial' named entity 'respiratory syncytial virus' named entity 'glycoproteins' named entity 'cow's milk' named entity 'protein' named entity 'glycoprotein' named entity 'chronic inflammation' named entity 'colostrum' named entity 'coronavirus' named entity 'immune sera' named entity '1, 2' named entity 'pathogens' named entity 'bovine' named entity 'respiratory syncytial virus' named entity 'IgG' named entity 'colostrum' named entity 'pathogens' named entity 'Agence Nationale de la Recherche' named entity 'animal models' named entity 'IgG' named entity 'colostrum' named entity 'Fcγ receptors' named entity 'colostrum' named entity 'Cryptosporidium' named entity 'SARS-CoV-2' named entity 'immunoglobulin' named entity 'small intestine' named entity 'bovine' named entity 'colostrum' named entity 'TLR' named entity 'Bovine' named entity 'plasma' named entity 'HIV' named entity 'colostrum' named entity 'human immunodeficiency virus' named entity 'enveloped viruses' named entity 'Odong' named entity 'bovine' named entity 'metabolism' named entity 'blocking antibodies' named entity 'CD8+ T cells' named entity 'colostrum' named entity 'infection' named entity 'trypsin inhibitors' named entity 'bovine' named entity 'colostrum' named entity 'SARS-CoV-1' named entity 'SARS-CoV-2' named entity 'neutralizing antibodies' named entity 'vaccination' named entity 'critically ill patients' named entity 'clinical trials' named entity 'colostrum' named entity 'IgG1' named entity 'vaccination' named entity 'human milk' named entity 'vaccination' named entity 'transfusion' named entity 'vaccine' named entity 'convalescent plasma therapy' named entity 'IgG' named entity 'SARS-CoV-2' named entity 'colostrum' named entity 'SARS-CoV-2' named entity 'pathogen' named entity 'Bovine' named entity 'IgG' named entity 'IgM' named entity 'ERA' named entity 'IgG' named entity 'IgG'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software